Methotrexate Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9830

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 0143-9830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Methotrexate For Injection Usp 1)

Chemical structure of Methotrexate, illustrating its molecular framework with labeled functional groups and bonds.*

FDA Label Image

Methotrexate Lyo 1 Gram Label (Methotrexate For Injection Usp 2)

Methotrexate for Injection, USP 1 g/vial, sterile lyophilized powder for solution, preservative-free, cytotoxic agent. The label includes dosage and reconstitution instructions, storage conditions, manufacturer (THYMOGLAN PHARMAZIE GmbH, Germany), and distributor (WEST-WARD, Eatontown, NJ). The vial is single-use with specified routes including intra-arterial, intramuscular, intrathecal, and intravenous.*

FDA Label Image

Methotrexate For Injection Usp 3

Label showing a lot number, expiration date, GTIN barcode, and serial number for Methotrexate injection, lyophilized powder for solution, strength 1 g/1, by Hikma Pharmaceuticals USA Inc. The label includes a 2D barcode and human-readable alphanumeric identifiers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.